Skip to main content
HOPA Abstracts
Effectiveness of High-Dose Intravenous Acyclovir in Preventing Cytomegalovirus Infection in Allogeneic Stem-Cell Transplantation Recipients: A Retrospective Study in a Medical Center in Singapore
Abstract #CR17
Read More
HOPA Abstracts
Trilaciclib Use and Chemotherapy-Induced Myelosuppression Among Patients with Extensive-Stage Small-Cell Lung Cancer in US Community Oncology Settings
Abstract #CR18
Read More
HOPA Abstracts
Urinary Tract Infections in Patients Receiving Chemotherapy and SGLT2 Inhibitors
Abstract #CR19
Read More
HOPA Abstracts
Use of Ursodiol for SOS/VOD Prophylaxis in Patients with Acute Leukemia Receiving Gemtuzumab-Ozogamicin or Inotuzumab-Ozogamicin
Abstract #CR20
Read More
HOPA Abstracts
Use of Bevacizumab Originator versus Biosimilar Drugs for Oncology Indications in a Real-World Data Sample
Abstract #CR21
Read More
HOPA Abstracts, Tyrosine Kinase Inhibitor
Veterans Health Administration Pharmacy Benefits Management Anti-Cancer Stewardship Pilot: Why Switch to a Second-Line Tyrosine Kinase Inhibitor for the Treatment of Chronic Myeloid Leukemia?
Abstract #CR22
Read More
HOPA Abstracts
Assessment and Education of Biosimilars Across an Outpatient Oncology Infusion Network
Abstract #CR23
Read More
HOPA Abstracts
Optimizing Corticosteroid Use for Immune-Related Adverse Events at a Community Oncology Practice
Abstract #LB01
Read More
HOPA Abstracts
Efficacy of Tixagevimab-Cilgavimab in Preventing SARS-CoV-2 in Patients with Hematologic Malignancies
Abstract #LB02
Read More
HOPA Abstracts
Potentially Inappropriate Medication Use and Cognition in Older Women with Breast Cancer
Abstract #LB03
Read More
Page 39 of 199
Results 381 - 390 of 1986